The "Middle Eastern Cancer and Oncology Journal (MECOJ)" is an online, peer-reviewed, open access journal that strives to push the boundaries of oncology by enhancing the understanding of cancer biology, evolving treatment methods, and effective prevention strategies. It is established in 2025 by OncoEval Pioneers Group and owned by Scientific Steps Groups which owns the copyright and licensing for all issues and articles in the journal. MECOJ serves as a critical platform for the swift publication of pioneering research that connects the intricate scientific findings with tangible clinical applications. The journal champions the exploration of innovative therapeutic approaches and groundbreaking genetic discoveries that redefine cancer care standards globally. Emphasizing both regional challenges in the Middle East and global advancements, the journal aims to foster collaborative insights that enhance cancer research and treatment outcomes worldwide.